IBO logo

IMPACT BIOMEDICAL INC

IBONYSE AMERICAN
🏆 #4486 by market capUS Equity
$3.73▲ $0.60 (+19.17%)
Pre-market · at close
🔔
Track IBO
Get earnings, price moves & breaking news on Telegram
Track
24h▲ 19.2%
7d▲ 19.2%
14d▼ 11.8%
30d▼ 35.9%
ytd▼ 36.8%
1y▼ 49.9%
🏦Market Cap
$32M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
82.1%
High
💵FCF Margin
—
⚖️P/S Ratio
910.5x
Expensive
Otter Score
—
Insufficient data

Trading Snapshot

Day Range
$3.71 – $3.73
52-Week Range
$2.43 – $10.47
Volume (shares)
1,228
Avg Volume (shares)
—
Shares Outstanding
8.5M
Next Earnings
—

Fundamentals Snapshot

Annual Revenue
$32,000
Last Q Revenue
$3,000
P/E Ratio
40.4
P/S Ratio
910.5x
EPS (TTM)
$-0.09
Dividend Yield
—
Dilution (1yr)
+174.1%
IBO logo

IMPACT BIOMEDICAL INC

IBO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$32K▲ +0.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-1225.0%▼ −1325.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
−$4M▼ −85.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
−$2M▼ −66.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.5M▲ +174.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$3K▲ +$7M YoY
StockOtter · stockotter.space

About IMPACT BIOMEDICAL INC

Houston, Texas-based Impact BioMedical Inc., founded in 2018, focuses on discovering and developing innovative products and therapeutic options for both specialty biopharmaceuticals and consumer healthcare markets. The company features several key technologies: its "Linebacker" platform utilizes small molecule electrophilically enhanced polyphenol compounds with potential applications in treating cancer, inflammatory diseases, and neurological conditions. Additionally, "Laetose" technology, a unique blend of sugar and inositol, is designed to counteract the inflammatory and metabolic responses usually triggered by sugar consumption. Impact BioMedical also creates "functional fragrance formulations," which are a series of fragrances incorporating specialized botanical ingredients for antimicrobial purposes, or as active additives in items like insect repellents, cleaning products, personal care items, and fabrics. Rounding out its offerings is the "Equivir/Equivir G" technology, a distinctive mix of polyphenols that has exhibited antiviral properties, suitable for use in health supplements and medications.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

💎Quality★★★★★
⚖️Valuation★★★★★
💧Dilution★★★★★
Overall Score
Insufficient data
—/100
Analyst data unavailable.

Latest News & Updates

News unavailable.